Spire Healthcare Group PLC

Remuneration Information • Oct 8, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3329D

Spire Healthcare Group PLC

08 October 2018

8 October 2018

Spire Healthcare Group plc

Grant of 2018 Long Term Incentive Plan awards

Spire Healthcare Group plc (the "Company") announces that, on 8 October 2018, a performance share award (the "Award") was granted over the Company's ordinary shares in the form of nil cost options to the following Executive Director in the Company, under the rules of the Spire Healthcare Group plc Long Term Incentive Plan.

Name                         Maximum number of shares under Award

Jitesh Sodha             415,381

The number of shares set out above is the maximum number which may vest under the Award following the cessation of the performance period. The actual number of shares which vest will depend on the extent to which the following performance conditions have been satisfied.

The performance conditions applicable to the Award will be based as follows:

·    35% on relative total shareholder return (TSR) performance;

·    35% on adjusted earnings per share (EPS) performance; and

·    30% on two Operational Excellence measures.

Furher details of these performance conditions were disclosed in the 2017 Directors' Remuneration Report which was published in April.

The share price used to determine the number of shares under the Award was £1.4264 being the average of the middle market quotation over the last five dealing days ending on 5 October 2018.

The transaction place is London.

Name of contact and telephone number for queries:

Philip Davies                                                 020 7427 9092

Deputy Company Secretary

The following disclosure is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.

a)	Name	Jitesh Sodha
2	Reason for the notification
a)	Position/status	Chief Financial Officer and Executive Director
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Spire Healthcare Group plc
b)	LEI	213800IBJPW3SE2RA350
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 1 pence each GB00BNLPYF73
b)	Nature of the transaction	Grant of performance share awards under the Company's Long Term Incentive Plan
c)	Price(s) and volume(s)	Price(s)	Volume(s)
Nil	415,381
d)	Aggregated information - Aggregated volume - Price	As above
e)	Date of the transaction	2018-10-08
f)	Place of the transaction	XLON

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHBSBDGXUGBGII